No Data
No Data
Home Healthcare Inflation Is Stubbornly High -- WSJ
Express News | Maxim Group Reiterates Buy on HeartSciences, Maintains $12 Price Target
HeartSciences Analyst Ratings
HeartSciences Withdraws June 2023 Filing for Potential Stock Sale
Heart Test Laboratories Q2 EPS $(2.27) Beats $(2.43) Estimate
HeartSciences: Saw Across-the-Bd Progress, Positive Developments for Field of AI-ECG, MyoVista WavECG Device, MyoVista Insights Cloud-Native Platform and First Cloud-Based AI-ECG Algorithms >HSCS